Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Surveillance; AZILVA Tablets and AZILVA Granules 1% in Pediatric Use

NCT05107960 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05107960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05107960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Surveillance; AZILVA Tablets and AZILVA Granules 1% in Pediatric Use
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
December 16, 2021
Completion date
August 31, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension